Medical cannabis could replace risky sleep drugs, studies reveal
Medical cannabis may offer a safer alternative to addictive sleep medications. Recent studies suggest it improves sleep quality quickly and without the risks linked to conventional drugs. The findings come as concerns grow over the widespread use of benzodiazepines, which often lead to dependence.
A U.S. study tracked 137 patients using medical cannabis for sleep disorders over 12 months. Results showed rapid improvements in sleep quality, measured by the Pittsburgh Sleep Quality Index (PSQI). These benefits remained steady, with no decline or further increase during the full year of treatment.
The method of consumption—whether oils, edibles, or inhalation—made no difference to the results. Meanwhile, a British study reported similar outcomes, with patients experiencing better sleep and mental well-being. Only 9% of participants noted mild side effects. In Germany, benzodiazepines remain a common treatment for sleep problems, despite their risks. Around one in twenty Germans receives a prescription for these drugs annually, with up to 1.5 million people dependent on them. Cannabis, with its sedative properties, could reduce reliance on such high-risk medications.
The studies highlight cannabis as a potential long-term solution for sleep disorders. Patients saw sustained improvements without the dependence issues tied to benzodiazepines. Researchers suggest further exploration of its role in sleep medicine could provide safer treatment options.
